You are here

Article info

Article menu
Download PDFPDF
Clinical science
Type 3 neovascularisation: long-term analysis of visual acuity and optical coherence tomography anatomical outcomes

Authors

  • Bora Chae Stein Eye Institute, University of California, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Daniel Su Stein Eye Institute, University of California, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Orly Gal-Or Vitreous, Retina Macula, Consultants of New York, New York City, New York, USA LuEsther T Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, New York, USA Department of Ophthalmology, Rabin Medical Center, Petach Tikva, Israel PubMed articlesGoogle scholar articles
  • K Bailey Freund Vitreous, Retina Macula, Consultants of New York, New York City, New York, USA LuEsther T Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, New York, USA Department of Ophthalmology, New York University School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • David Sarraf Stein Eye Institute, University of California, Los Angeles, California, USA Department of Ophthalmology, Kaiser Permanente, Woodland Hills, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David Sarraf, Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute, UCLA Geffen School of Medicine, Los Angeles, CA 90095, USA; dsarraf{at}ucla.edu
View Full Text

Citation

Chae B, Su D, Gal-Or O, et al
Type 3 neovascularisation: long-term analysis of visual acuity and optical coherence tomography anatomical outcomes
British Journal of Ophthalmology 2019;103:43-48.

Publication history

  • Received January 4, 2018
  • Revised February 14, 2018
  • Accepted February 17, 2018
  • First published March 8, 2018.
Online issue publication 
December 14, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.